SCHEMBL7839729

SCHEMBL7839729

CCOC(=O)C(c1ccc2c(c1)OCO2)C(C=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
SOAT1 P35610 2/20 0.43
HIF1A Q16665 1/20 0.43
EPAS1 Q99814 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
MAPT P10636 4/20 0.42
STAT1 P42224 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7845530 0.93 KMT2A (0.43) TP53KMT2AMEN1POLBRAB9A
SCHEMBL7844615 0.91 TP53 (0.46) TP53KMT2AMEN1POLBRAB9A
SCHEMBL8152135 0.87 KMT2A (0.57) TP53KMT2AMEN1POLBRAB9A
SCHEMBL7841290 0.85 RAB9A (0.46) KMT2APOLBRAB9ANPC1MAPT
SCHEMBL7842233 0.85 KMT2A (0.40) TP53KMT2AMEN1POLBRAB9A
SCHEMBL7831716 0.84 RAB9A (0.44) KMT2AMEN1POLBRAB9ANPC1
SCHEMBL7842489 0.84 RAB9A (0.44) KMT2AMEN1RAB9ANPC1MAPT
SCHEMBL7839027 0.84 KDM4E (0.49) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL7838582 0.83 MAPT (0.55) KMT2AMEN1POLBRAB9ANPC1
SCHEMBL7838868 0.82 HPGD (0.41) KMT2AMEN1RAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882030-B1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GMBH (DE) 2001-09-12 EP disclosed
US-6017939-A 2,1,3-benzothia(OXA)diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GESELLSCHAFT (DE) 2000-01-25 US disclosed
EP-0882030-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-09 EP disclosed
WO-1997030982-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 WO disclosed